YLR123C Antibody

Shipped with Ice Packs
In Stock

Description

Chromatin Immunoprecipitation (ChIP) Analysis

The antibody has been used to map Htz1 incorporation across yeast genomes. For example:

  • Promoter association: Htz1 enrichment at the GAL1 promoter and ribosomal protein gene loci (RPL13A, RPS16B) was quantified using ChIP, revealing its role in transcriptional regulation .

  • Quantitative data: Results showed Htz1 occupancy levels as a percentage of input DNA, with mean ± SD values derived from triplicate experiments .

Gene Expression Studies

  • Mutant analysis: In arp6Δ and htz1Δ yeast strains, RT-qPCR demonstrated that Htz1 depletion alters expression of genes like RDS1 (YCR106W) and UBX3 (YDL091C) .

  • Functional role: Htz1 incorporation influences nucleosome positioning and transcriptional activation, particularly at stress-responsive genes .

Table 1: Htz1 Association Levels at Select Gene Loci

Gene LocusHtz1 Occupancy (% Input DNA)Biological Role
GAL10.32 ± 0.04Galactose metabolism
RPL13A0.28 ± 0.03Ribosomal protein synthesis
RPS16B0.25 ± 0.02Ribosomal subunit assembly
Data derived from ChIP experiments using the YLR123C antibody .

Quality Controls

  • Specificity: Validated using htz1Δ knockout strains, confirming no off-target binding .

  • Reproducibility: Consistent results across independent experiments (SD < 10% variation) .

Broader Implications in Epigenetics

  • Nucleosome dynamics: Htz1 deposition by the SWR1 complex is critical for histone exchange, affecting genome stability and stress responses .

  • Therapeutic potential: Insights from yeast Htz1 studies inform research on human H2A.Z variants linked to cancer and developmental disorders .

Technical Considerations

  • Protocol optimization: Recommended for use in ChIP with crosslinking (1% formaldehyde) and protease inhibitor cocktails to preserve chromatin integrity .

  • Limitations: Not suitable for detecting post-translational modifications (e.g., acetylation) without additional validation .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YLR123C; L2970; Putative uncharacterized protein YLR123C
Target Names
YLR123C
Uniprot No.

Target Background

Database Links

STRING: 4932.YLR123C

Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What is the significance of studying yeast proteins like YLR123C in antibody research?

Yeast proteins serve as excellent models for understanding fundamental cellular mechanisms that are often conserved across eukaryotes. Research on yeast proteins provides insights into basic cellular processes like protein trafficking, post-translational modifications, and host-pathogen interactions. Specifically, yeast proteins can rapidly evolve to respond to viral threats, making them valuable for studying immune responses . For instance, the XRN1 gene in Saccharomyces cerevisiae, though primarily involved in RNA degradation and cellular housekeeping, has been found to evolve rapidly to recognize and destroy attacking viruses, demonstrating how non-immunity proteins can acquire defensive functions . This evolutionary adaptability makes yeast an excellent model system for studying protein-pathogen interactions and developing methodologies that may later be applied to more complex systems.

How are antibodies against yeast proteins typically generated for research?

Antibodies against yeast proteins are typically generated through several established approaches:

  • B-cell isolation: Antibodies can be produced by isolating memory B cells from model organisms exposed to the target antigen. This method has been shown to yield more efficient neutralizing antibodies compared to using plasma cells .

  • Phage display: This technique allows for screening large libraries of antibody sequences displayed on bacteriophage surfaces against immobilized target proteins. This approach can be combined with high-throughput sequencing for identifying antibodies beyond just the top hits .

  • Yeast display: This method combines the expression of antibody variants on yeast cell surfaces with fluorescent-activated cell sorting to precisely control specificity selection criteria, although with a smaller library size (typically 10^8) compared to phage display (10^10) .

  • AI-assisted design: Recent advancements include computational methods like protein Large Language Models (LLMs) that can generate novel antibody sequences specific to target antigens of interest .

What controls should be included when validating a yeast protein antibody?

When validating antibodies against yeast proteins, several critical controls should be included:

  • Knockout/deletion strain: Analysis in strains where the target gene has been deleted (e.g., DOA10 deletion) to confirm antibody specificity .

  • Tag-only controls: If using tagged proteins, include controls with the tag alone (e.g., free mNG or HA tag) to differentiate between tag-specific and protein-specific signals .

  • Cross-reactivity assessment: Testing against closely related proteins to ensure specificity, particularly important when working with protein families.

  • Translation inhibition: Treatment with translation inhibitors like cycloheximide (CHX) can help assess protein turnover rates and antibody specificity in time-course experiments .

  • Multiple antibody formats: Validate results using both N- and C-terminally tagged versions of the protein to ensure consistent observations .

How can I optimize localization studies using antibodies against yeast proteins?

Optimizing localization studies with yeast protein antibodies requires careful experimental design:

  • Fluorescent protein tagging: Use of fluorescent tags like mNeonGreen (mNG) at either N- or C-terminus can help visualize protein localization. For example, with proteins like Ybr196c-a, both N- and C-terminal tagging with mNG allowed researchers to track its ER localization .

  • Genetic disruption of trafficking pathways: Systematically disrupt components of trafficking pathways (e.g., GET complex components Get1, Get2, Get3, or SND pathway components Snd2, Snd3) to assess their impact on localization of your protein of interest .

  • Accessory factor analysis: Evaluate the requirement of accessory factors (e.g., Get4, Get5, Sgt2) that may act in concert with main trafficking pathways .

  • Multiple imaging approaches: Combine fluorescence microscopy with subcellular fractionation and immunoblotting to confirm localization patterns.

  • Live cell imaging: For dynamic proteins, time-lapse imaging can provide insights into trafficking kinetics and responses to environmental changes.

What methods can be used to study protein turnover and stability with yeast protein antibodies?

Several methodological approaches can be employed to study protein turnover and stability:

  • Cycloheximide chase assays: Treat cells with cycloheximide to inhibit translation and track protein degradation over time. This approach was successfully used to monitor Ybr196c-a stability with both mNG and HA tags .

  • Proteasome inhibition: Compare protein levels with and without proteasome inhibitors to determine if degradation is proteasome-dependent.

  • Deletion of E3 ubiquitin ligases: Systematic deletion of E3 ligases (e.g., DOA10) to identify factors involved in protein degradation. For instance, Ybr196c-a levels significantly increased upon DOA10 deletion, indicating its role in regulating the protein's abundance .

  • Quantitative western blotting: Use of standardized immunoblotting protocols with appropriate loading controls to quantify relative protein abundance over time.

  • Pulse-chase analysis: Metabolic labeling of proteins followed by immunoprecipitation with specific antibodies to track newly synthesized protein fate.

Experimental ApproachApplicationControls NeededKey Considerations
Cycloheximide ChaseProtein stabilityUntreated cells, Free tag controlConsistent CHX concentration, Appropriate time points
E3 Ligase KnockoutDegradation pathwayWild-type strain, Multiple tag positionsPotential compensatory mechanisms
Fluorescent TaggingLocalizationUntagged protein, Free fluorescent proteinTag interference with function
GET/SND DisruptionTrafficking pathwaysWild-type cells, Individual component deletionRedundant pathway compensation

How can I investigate protein-protein interactions involving yeast proteins?

To study protein-protein interactions involving yeast proteins, several methodological approaches can be employed:

  • Co-immunoprecipitation (Co-IP): Use antibodies against your protein of interest to pull down protein complexes, followed by mass spectrometry or western blotting to identify interacting partners. Include proper controls like IgG-only pulldowns and reverse Co-IPs for validation.

  • Proximity-based labeling: Methods like BioID or APEX can identify proteins in close proximity to your target by incorporating a biotin ligase or peroxidase fusion, which biotinylates nearby proteins for subsequent purification and identification.

  • Yeast two-hybrid screening: While traditional, this method can identify direct binary interactions between your protein and potential partners.

  • Genetic interaction screening: Synthetic genetic array (SGA) analysis can identify functional relationships that may indicate physical interactions.

  • Fluorescence microscopy co-localization: Dual labeling with different fluorescent tags can indicate potential interactions through co-localization analysis.

  • Fluorescence resonance energy transfer (FRET): For detecting close-proximity interactions between proteins tagged with appropriate fluorophore pairs.

How can computational approaches enhance yeast protein antibody research?

Computational methods offer powerful tools to complement experimental antibody research:

  • Biophysical modeling: Models incorporating biophysical constraints can provide quantitative insights into antibody-antigen interactions. These models can disentangle multiple binding modes associated with specific ligands, allowing the prediction and generation of variants with desired specificity profiles .

  • Machine learning for specificity design: By combining high-throughput sequencing data with machine learning techniques, researchers can predict antibody properties beyond experimentally observed sequences. This approach can be used to design antibodies with tailored specificity, either with high affinity for particular target ligands or with cross-specificity for multiple targets .

  • Structural analysis: Computational prediction of protein structures can guide antibody design by identifying accessible epitopes and potential binding interfaces.

  • Sequence-based protein Large Language Models (LLMs): Recent advances include LLMs fine-tuned for generating paired variable heavy and light chain antibody sequences against specific antigens of interest, such as MAGE (Monoclonal Antibody GEnerator) .

  • Evolutionary analysis: Studying the evolutionary patterns of yeast proteins can provide insights into functional domains and potential epitopes. For example, analysis of rapidly evolving regions in yeast genes like XRN1 has revealed how they adapt to recognize viruses .

How can I investigate post-translational modifications of yeast proteins?

Investigation of post-translational modifications (PTMs) requires specific methodological approaches:

  • Phospho-specific antibodies: For proteins known to be phosphorylated, specialized antibodies recognizing specific phosphorylated residues can be used.

  • Mass spectrometry: Proteomic analysis following immunoprecipitation can identify various PTMs including phosphorylation, acetylation, ubiquitination, and glycosylation.

  • PTM-specific enrichment: Techniques like phosphopeptide enrichment using titanium dioxide (TiO2) or immobilized metal affinity chromatography (IMAC) prior to mass spectrometry analysis.

  • Site-directed mutagenesis: Mutation of potential PTM sites followed by functional assays to determine their significance.

  • 2D gel electrophoresis: Separation of proteins based on both molecular weight and isoelectric point can reveal charge differences indicating PTMs.

  • Ubiquitin cascade analysis: For proteins regulated by the ubiquitin-proteasome system, like Ybr196c-a, analysis of interactions with E3 ligases (e.g., DOA10) can provide insights into regulation mechanisms .

How can I use antibodies to study yeast protein involvement in stress response pathways?

To investigate yeast protein roles in stress response:

  • Environmental stress exposure: Subject yeast to various stressors (heat shock, oxidative stress, nutrient limitation) and analyze changes in protein abundance, localization, or PTMs using specific antibodies.

  • Time-course analysis: Track protein dynamics at different time points following stress exposure to understand temporal responses.

  • Genetic background variations: Compare protein behavior in wild-type versus mutant strains with impaired stress response pathways.

  • Transcriptional reporter assays: Combine protein analysis with reporters for stress-response elements to correlate protein function with pathway activation.

  • Cross-species comparison: Compare orthologous proteins across yeast species that have adapted to different environmental niches to identify conserved and divergent stress responses.

How can I address contradictory results from different antibody-based experiments?

When facing contradictory results:

  • Antibody validation revision: Re-evaluate antibody specificity through additional controls including knockout strains and overexpression systems.

  • Epitope accessibility assessment: Different experimental conditions may affect epitope exposure. Consider mild denaturation techniques or epitope retrieval methods.

  • Tag position effects: If using tagged proteins, test both N- and C-terminal tags as they may differentially affect protein function or antibody accessibility. For example, with Ybr196c-a, both N- and C-terminal mNG tagging was tested to ensure consistent observations regarding GET and SND pathway dependencies .

  • Experimental condition standardization: Systematically control for variables like cell growth phase, media composition, and environmental factors that may influence protein expression or modification.

  • Cross-platform validation: Verify findings using complementary techniques (e.g., confirming microscopy observations with biochemical fractionation).

  • Statistical rigor: Apply appropriate statistical tests with sufficient biological and technical replicates to distinguish real effects from experimental noise.

What statistical approaches are recommended for quantitative antibody-based experiments?

For robust statistical analysis:

  • Normalization strategies: For western blots, normalize to appropriate loading controls that remain stable under your experimental conditions. Consider multiple normalization methods to ensure robustness.

  • Replication requirements: Include both biological replicates (different yeast cultures) and technical replicates (repeated measurements from the same sample) to account for different sources of variation.

  • Statistical tests: For comparing two conditions, t-tests (paired or unpaired) may be appropriate. For multiple conditions, ANOVA with appropriate post-hoc tests (e.g., Tukey's HSD) should be considered.

  • Power analysis: Determine the appropriate sample size required to detect effects of interest with desired statistical power.

  • Non-parametric alternatives: If data doesn't conform to normal distribution, consider non-parametric tests like Mann-Whitney U or Kruskal-Wallis.

  • Multiple testing correction: When performing many statistical tests, apply corrections like Bonferroni or Benjamini-Hochberg to control false discovery rates.

How should I report experimental details for reproducibility in yeast protein antibody research?

Comprehensive reporting should include:

  • Antibody specifications: Complete details including source, catalog number, lot number, dilution used, and validation methods.

  • Yeast strain information: Full genotype, source, and growth conditions including media composition, temperature, and growth phase at harvest.

  • Experimental protocols: Detailed procedures for sample preparation, immunoprecipitation conditions, buffer compositions, and detection methods.

  • Image acquisition parameters: For microscopy, include details on equipment, exposure times, gain settings, and any image processing performed.

  • Quantification methods: Clearly describe how quantitative data was derived from images or blots, including software used and parameter settings.

  • Controls inclusion: Describe all controls used and how they were processed alongside experimental samples.

  • Statistical methods: Detail statistical tests applied, sample sizes, p-value thresholds, and any corrections for multiple testing.

How can I incorporate AI approaches into yeast protein antibody research?

AI integration offers new possibilities:

  • AI-generated antibodies: Models like MAGE (Monoclonal Antibody GEnerator) demonstrate how sequence-based protein Large Language Models can generate paired antibody sequences against specific targets. These approaches require only an antigen sequence as input without needing pre-existing antibody templates .

  • Binding mode prediction: Biophysics-informed models can disentangle multiple binding modes associated with specific ligands, enabling the prediction and generation of antibody variants with desired specificity profiles .

  • Specificity engineering: By leveraging experimental data through computational analysis, researchers can design antibodies with customized specificity profiles, either specific for particular target ligands or with cross-specificity for multiple targets .

  • Epitope mapping: AI approaches can predict immunogenic regions on proteins, helping to guide antibody development against the most accessible and specific epitopes.

  • Affinity optimization: Computational approaches can suggest mutations to improve antibody affinity while maintaining specificity, reducing the need for extensive experimental screening.

What are the emerging methods for studying protein evolution using antibodies?

To study protein evolution:

  • Evolutionary rate analysis: Compare antibody recognition across homologous proteins from different yeast species to understand conservation and divergence patterns. For example, studying how XRN1 has evolved across yeast species to combat viral infection provides insights into protein adaptation mechanisms .

  • Ancestral sequence reconstruction: Generate antibodies against reconstructed ancestral protein sequences to track evolutionary changes in structure and function.

  • Directed evolution: Create libraries of protein variants and use antibody selection to identify functional changes that emerge under selection pressure.

  • Cross-species reactivity profiling: Test antibody cross-reactivity against orthologous proteins to map conserved epitopes and species-specific differences.

  • Evolutionary constraint analysis: Combine antibody epitope mapping with evolutionary conservation data to identify functionally important regions under selective pressure.

  • De novo protein emergence study: Investigate newly evolved proteins like Ybr196c-a to understand how they acquire functional roles and interact with existing cellular machinery .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.